Farxiga (dapagliflozin) treats type 2 diabetes, heart failure, and chronic kidney disease, and without help it's genuinely expensive — brand-name pricing runs anywhere from roughly $550 to $780 for a single 30-day supply. AstraZeneca's savings card can bring that down sharply for some patients, but the terms are more specific than most coupon sites let on, and two changes in 2026 reshuffled the whole picture: the arrival of a real generic, and AstraZeneca winding down free assistance for the brand. This guide walks through exactly who the card helps, who it doesn't, and what actually makes sense for your situation right now.
1. What Is the Farxiga Savings Card?
The Farxiga Savings Card is AstraZeneca's manufacturer copay assistance program for brand-name Farxiga (dapagliflozin) tablets. It works at the pharmacy counter like a copay card, not a printable coupon: your pharmacist applies it to your prescription and it reduces what you owe based on your insurance situation.
| Situation | What You Pay | Cap |
|---|---|---|
| Commercially insured | As low as $0 per 30-day supply | Up to $175 in savings per fill |
| Uninsured / cash-pay | Pharmacy price minus AstraZeneca's contribution | AstraZeneca pays up to the first $150 |
| Medicare or Medicaid | Not eligible for this card | Different rules apply — see below |
Read the cash-pay terms carefully. "Up to $150" is a contribution toward the price, not a $150 total cost. If your pharmacy charges $650 for Farxiga and you're uninsured, the card can knock $150 off — you're still responsible for roughly $500.
2. Big Update: A Generic Farxiga Now Exists
This is the single most important change for anyone researching Farxiga savings in 2026. On April 6–7, 2026, the FDA approved the first generic versions of dapagliflozin, and more than a dozen manufacturers launched immediately once the core patent expired. That's a real, stocked generic — not just an FDA approval sitting on a shelf waiting for patent litigation to clear.
Why it matters for your wallet: Choosing generic dapagliflozin and applying a free discount coupon can save roughly $460 a month compared to unassisted brand pricing, according to pharmacy pricing trackers. For a lot of uninsured patients, that beats what's left over after the brand card's $150 cash-pay contribution.
One important catch: the current generic label covers type 2 diabetes glycemic control and reducing heart failure hospitalization risk in patients with type 2 diabetes plus cardiovascular disease or risk factors. It does not yet carry brand Farxiga's separate chronic kidney disease indication, or the broader heart failure indication for patients without diabetes. If you take Farxiga specifically for CKD or for heart failure and you don't have type 2 diabetes, ask your prescriber before switching — a straight swap may not be appropriate yet.
This is also exactly why AstraZeneca is winding down free Farxiga assistance through AZ&Me — more on that below. For context, Jardiance (empagliflozin), a competing SGLT2 inhibitor, still has no FDA-approved generic as of 2026, which is part of why Farxiga's savings landscape looks so different from its closest rival right now.
3. Is There a Farxiga Coupon or Manufacturer Coupon?
AstraZeneca does not issue a traditional printable manufacturer coupon for Farxiga. When people search for a "Farxiga coupon" or "Farxiga manufacturer coupon," they're almost always describing the same benefit as the Farxiga Savings Card above — it functions like a coupon at checkout, but it's structured as a copay card with the insurance-based terms described in Section 1.
| Search Term | What Actually Exists |
|---|---|
| Farxiga coupon | Farxiga Savings Card (manufacturer copay program) |
| Farxiga manufacturer coupon | Same Farxiga Savings Card — no separate printable coupon |
| Farxiga copay card | Same program, insurance-based terms |
| Coupon for Farxiga without insurance | Cash-pay version of the same card — up to $150 off, not $150 total |
| Third-party Farxiga discount card | GoodRx, SingleCare, Inside Rx — can't be combined with the manufacturer card |
Bottom line: If a site advertises a printable "Farxiga coupon," it's referring to this same manufacturer program, or to an independent pharmacy discount card that may or may not beat it. Compare both before you commit — see our GoodRx vs. Inside Rx comparison for how those independent cards typically stack up.
4. Farxiga Copay Card: $0 for Commercially Insured
If you have commercial insurance — through an employer or the ACA marketplace — and your plan's copay or coinsurance for Farxiga is higher than you'd like, the savings card applies at the pharmacy and can bring your out-of-pocket cost down to $0 for a 30-day supply, up to a maximum benefit of $175 per fill.
- Works automatically at most participating pharmacies once registered.
- Applies per 30-day fill, not as a one-time benefit.
- Non-transferable and limited to one card per person; can't be combined with any other discount on the same fill.
Copay accumulator programs can undo this. A growing number of insurers use copay accumulator or maximizer programs that apply the manufacturer's payment to your bill but don't count it toward your deductible or out-of-pocket maximum. That means you could face a larger bill later in the year for other medications. Ask your insurer directly: "Does my plan have a copay accumulator or maximizer program for brand-name drugs?"
5. Farxiga Savings Card Without Insurance
Uninsured patients are eligible for the same card, but the math works differently. AstraZeneca contributes up to the first $150 toward your pharmacy's cash price for each monthly prescription, and you pay whatever is left.
| Pharmacy Cash Price | AstraZeneca's Contribution | Your Remaining Balance |
|---|---|---|
| ~$550 | $150 | ~$400 |
| ~$650 | $150 | ~$500 |
| ~$780 | $150 | ~$630 |
This is why so many uninsured patients are better off with generic dapagliflozin plus a free discount coupon than with the brand card's cash-pay benefit. Compare both at your specific pharmacy using a tool like our Drug Price Checker before you decide.
6. AZ&Me Is Closing for Farxiga (2026 Update)
AZ&Me is AstraZeneca's separate, income-based patient assistance program that has historically provided free medication to qualifying uninsured patients. As of May 1, 2026, it stopped accepting new patients for Farxiga and Xigduo XR.
- Currently enrolled patients can keep receiving free Farxiga or Xigduo XR through December 31, 2026.
- Final day to request a refill under the program is December 15, 2026.
- AstraZeneca's stated reason: broad generic dapagliflozin availability beginning in April 2026 made continued free brand assistance unnecessary for most patients going forward.
- Standard AZ&Me income eligibility for primary and specialty medications remains at or below 300% of the Federal Poverty Level.
If you were counting on AZ&Me and haven't applied yet, you're too late for Farxiga specifically. New applications for Farxiga and Xigduo XR are no longer being accepted. If you already need ongoing assistance, ask your prescriber about generic dapagliflozin, check the patient assistance program directory for other manufacturer or nonprofit options, or use NeedyMeds and BenefitsCheckUp to screen for other programs you may qualify for.
7. Farxiga Cost: Brand vs. Card vs. Generic
| Option | Typical Monthly Cost | Best For |
|---|---|---|
| Brand Farxiga, no assistance | ~$550–$780 | Not recommended if any assistance applies |
| Brand Farxiga + Savings Card, commercial insurance | $0 (up to $175 off) | Commercially insured patients |
| Brand Farxiga + Savings Card, uninsured | ~$400–$630 (price minus $150) | Uninsured patients who need the brand specifically |
| Generic dapagliflozin + free coupon | Often well under $150 | Most uninsured patients whose indication is covered by the generic label |
| Medicare Part D | ~$38.82 average | Medicare enrollees, per AstraZeneca's published 2026 average |
See our Medicare Part D overview for how formulary tiers and the annual out-of-pocket cap affect what you'll actually pay through a Part D plan, and our Extra Help (LIS) guide if your income is limited and you're on Medicare.
8. Eligibility & Who Qualifies
Commercial Insurance
Employer-sponsored or ACA marketplace plans qualify for the $0, $175-cap benefit.
Uninsured / Cash-Pay
Qualifies for the cash-pay benefit — AstraZeneca contributes up to $150 per fill.
Medicare
Excluded from this card. Part D pricing and Extra Help apply instead.
Medicaid
Excluded from this card. State Medicaid formulary rules apply instead.
9. Income Limits Compared
The Farxiga Savings Card has no income requirement at all — it's based purely on insurance status. AZ&Me, by contrast, is strictly income-based, which is a common point of confusion.
| Program | Income Limit | Insurance Requirement |
|---|---|---|
| Farxiga Savings Card | None | Commercial insurance or uninsured |
| AZ&Me (Farxiga, legacy enrollees only) | ≤300% of Federal Poverty Level | Uninsured or Medicare without Extra Help |
| Medicare Extra Help (LIS) | Varies — tied to federal thresholds updated annually | Enrolled in Medicare Part D |
10. Covered Medications Compared
| Product | Savings Card | AZ&Me | Notes |
|---|---|---|---|
| Farxiga (dapagliflozin) tablets | Yes | New patients: no | Core focus of this guide |
| Xigduo XR (dapagliflozin + metformin) | Yes, separate card | New patients: no | Same 2026 phase-out timeline as Farxiga |
| Generic dapagliflozin | Not applicable — brand-only program | Not applicable | Covered by standard pharmacy discount coupons instead |
| Jardiance (empagliflozin) | Different manufacturer program | Different manufacturer program | No generic available as of 2026 |
11. How to Enroll Step-by-Step
Confirm your insurance status
Commercial insurance and uninsured cash-pay both qualify for the Farxiga Savings Card; Medicare and Medicaid do not. Know which bucket you're in before you start.
Register for the card
Sign up through AstraZeneca's official Farxiga savings page to activate your card, whether you're insured or paying cash.
Ask your prescriber about generic dapagliflozin
If your Farxiga prescription is for type 2 diabetes or the covered heart failure indication, ask whether the generic is appropriate — it may be far cheaper than the brand card's remaining balance.
Present your card (or a discount coupon) at the pharmacy
Hand over the Farxiga Savings Card for brand-name Farxiga, or a free discount coupon if you and your prescriber have chosen generic dapagliflozin instead.
Confirm the price before you pay
Ask the pharmacist to show you the price after the discount is applied. If it doesn't look right, ask them to re-run it as a manufacturer copay card for dapagliflozin.
12. Approval Timelines
| Program | Typical Timeline |
|---|---|
| Farxiga Savings Card (commercial) | Immediate at pharmacy counter once registered |
| Farxiga Savings Card (cash-pay) | Immediate — no waiting period |
| AZ&Me (legacy enrollees only) | Typically 2–4 weeks for renewals; new Farxiga applications are closed |
| Prior authorization, if your plan requires it | Usually 3–14 business days, longer if appealed |
If your Farxiga or generic dapagliflozin prescription is stuck in review, our prior authorization guide covers documentation that typically speeds up approval.
13. Renewal Process
AstraZeneca republishes Farxiga Savings Card terms periodically, generally on a calendar-year cycle. Set a reminder near the start of each year to confirm your card is still active and that the terms — the $175 commercial cap and $150 cash-pay contribution — haven't changed. If your pharmacy suddenly stops applying the discount mid-year, that's usually the first sign a renewal is needed.
AZ&Me enrollees who are grandfathered in for Farxiga should watch two dates closely: December 15, 2026 (final refill request) and December 31, 2026 (full program removal). There is no renewal path after that for Farxiga specifically.
14. Decision Path: Which Option Fits You?
For most people, this comes down to two real contenders: the brand savings card (best if commercially insured) or generic dapagliflozin with a free coupon (often best if uninsured). Price both at your specific pharmacy before you decide.
15. Real Patient Examples
Her employer plan puts Farxiga on a high copay tier. Registering for the Farxiga Savings Card brings her cost to $0 per fill, well under the $175 cap.
His pharmacy quotes $620 for brand Farxiga. The cash-pay card knocks off $150, leaving $470. His doctor confirms generic dapagliflozin is appropriate, and with a free coupon he pays a small fraction of that instead.
She takes Farxiga specifically for CKD and doesn't have type 2 diabetes, so the current generic label doesn't clearly cover her use. She stays on brand Farxiga and uses the Savings Card's commercial-insurance benefit through her plan.
16. Pros and Cons
Pros
- No income requirement for the Savings Card itself
- Can reach $0 out-of-pocket for commercially insured patients
- A real, stocked generic now exists as a lower-cost fallback
- Instant activation — no application review or waiting period
Cons
- Cash-pay benefit only offsets $150 — not a flat low price
- Excludes Medicare and Medicaid entirely
- AZ&Me is closed to new Farxiga applicants as of May 2026
- Generic doesn't yet cover the CKD or non-diabetic heart failure indications
17. Common Mistakes
Assuming the uninsured card caps your total cost at $150, instead of just reducing the price by up to $150.
Trying to apply for AZ&Me for Farxiga today — new applications closed on May 1, 2026.
Switching to generic dapagliflozin for CKD or non-diabetic heart failure without checking with your prescriber first.
Trying to use the Farxiga Savings Card while enrolled in Medicare or Medicaid.
Stacking a GoodRx or SingleCare coupon with the manufacturer card on the same fill.
Not asking about a copay accumulator program, which can quietly erase the benefit's effect on your deductible.